FIELMANN AG (ADR/1/5)O.N. - Asset Resilience Ratio
FIELMANN AG (ADR/1/5)O.N. (FIE1) has an Asset Resilience Ratio of 3.93% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of FIELMANN AG (ADR/1/5)O.N. to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how FIELMANN AG (ADR/1/5)O.N.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of FIELMANN AG (ADR/1/5)O.N..
Liquid Assets Composition Over Time
This chart breaks down FIELMANN AG (ADR/1/5)O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read FIELMANN AG (ADR/1/5)O.N. balance sheet liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €93.81 Million | 3.93% |
| Total Liquid Assets | €93.81 Million | 3.93% |
Asset Resilience Insights
- Limited Liquidity: FIELMANN AG (ADR/1/5)O.N. maintains only 3.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
FIELMANN AG (ADR/1/5)O.N. Industry Peers by Asset Resilience Ratio
Compare FIELMANN AG (ADR/1/5)O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 7.81% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.74% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753 |
Medical Instruments & Supplies | 1.44% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for FIELMANN AG (ADR/1/5)O.N. (2021–2024)
The table below shows the annual Asset Resilience Ratio data for FIELMANN AG (ADR/1/5)O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.31% | €7.39 Million ≈ $8.64 Million |
€2.37 Billion ≈ $2.77 Billion |
-0.82pp |
| 2023-12-31 | 1.13% | €22.91 Million ≈ $26.78 Million |
€2.02 Billion ≈ $2.36 Billion |
-4.45pp |
| 2022-12-31 | 5.58% | €98.62 Million ≈ $115.29 Million |
€1.77 Billion ≈ $2.07 Billion |
+2.09pp |
| 2021-12-31 | 3.49% | €60.65 Million ≈ $70.90 Million |
€1.74 Billion ≈ $2.03 Billion |
-- |
About FIELMANN AG (ADR/1/5)O.N.
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more